ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 059

Challenges Faced by Families of Children with an Auto-inflammatory Disease

Lori Tucker1, Maria Belen 2, Jenny Tekano 2, Iwona Niemietz 3, Martina Sundqvist 3 and Kelly Brown 3, 1BC Children's Hospital, Vancouver, British Columbia, Canada, 2BC CHildren's Hospital, Vancouver, Canada, 3BC Children's Hospital Research Institute, Vancouver, Canada

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Autoinflammatory Disease, Pediatric rheumatology, quality of life

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: Auto-inflammatory diseases (AIDs) are rare disorders that usually present in young children. Disease episodes, characterized by recurrent inflammation, are often frequent and unpredictable, and long-term outcomes are variable.  AIDs are not easily recognized by community health professionals, thus diagnosis may be delayed.  Our objective is to understand the challenges families experience prior to and after their child is diagnosed with an AID.

Methods: Parents of children followed in the AID clinic at BC Children’s Hospital (BCCH) between May-August 2019 were asked to participate. Parents completed a survey aimed to identify challenges faced prior to their child’s diagnosis, and resources families found helpful after diagnosis.  Likert scale and open-ended questions were included. Open-ended question results were grouped into themes for reporting. Summary descriptive statistics were applied as appropriate.  General demographic and clinical information (child’s current age, diagnosis, and age at diagnosis) were also collected.

Results: Fifty families completed the survey.  Their respective children with an AID had a median age of 11 y (range 4-18 y), 56% male.  Time from onset of AID symptoms to diagnosis was median 2 y (range 0.5-12 y).  Other family members with an AID were reported in 16% of families.  The most frequent diagnoses were PFAPA (n=17), CRMO (n=11), unclassified (n=6), and FMF (n=6).  At the time of their child’s diagnosis, 7-% of parents reported difficulty getting medical attention for their child’s illness, 78% worry about their child’s daily functioning and future, and the majority of parents noted a negative impact on their work (58% missing time from work, 62% changing work schedule), and significant parental stress, anxiety, and fatigue.  Open-ended questions revealed (i) parents feelings were not taken seriously by medical providers when seeking care, (ii) anxiety regarding diagnostic uncertainty, (iii) lack of confidence caring for their sick child, (iv) child missing school and activities, and (v) parents missing work to care for their ill child.   The most common resources parents used for support and information were health care professionals in the BCCH AID Clinic and online parent support groups.

Conclusion: Parents of children with AIDs share common challenges prior to their child’s diagnosis, including a substantial impact on their work and personal wellness.  Access to expertise in a specialty AID clinic provides important support to parents.  This needs assessment provides guidance for the development of education in the area of AIDs and parent support services that will improve coping for families of newly diagnosed children with AID.


Disclosure: L. Tucker, None; M. Belen, None; J. Tekano, None; I. Niemietz, None; M. Sundqvist, None; K. Brown, None.

To cite this abstract in AMA style:

Tucker L, Belen M, Tekano J, Niemietz I, Sundqvist M, Brown K. Challenges Faced by Families of Children with an Auto-inflammatory Disease [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/challenges-faced-by-families-of-children-with-an-auto-inflammatory-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/challenges-faced-by-families-of-children-with-an-auto-inflammatory-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology